Characterization of malinancy with FDG-PET

L.-F. de Geus-Oei

Promotor: W. Oyen, F. Corstens
Copromotor: P. Krabbe
Radboud University, Nijmegen, The Netherlands
November 19, 2007


Currently, there is an increasing interest in the oncological applications of FDG-PET beyond staging. This thesis focused on the utilization of FDG-PET as an imaging biomarker. Four diagnostic challenges on this topic were subject for investigation: the understanding of the underlying mechanisms of FDG accumulation, characterization of lesions, definition of high-risk populations and prediction of treatment outcome with FDG-PET. These topics were studied in three types of cancer: non-small-cell lung cancer (NSCLC), colorectal cancer and cancer of the head- and neck area.

A pdf file of this publication is available for personal use. Enter your e-mail address in the box below and press the button. You will receive an e-mail message with a link to the pdf file.